Back to mobile site

Intercept Pharma (ICPT) Falls 10% Ahead of Update on Phase 3 Trial of OCA

February 10, 2017 8:18 AM EST Send to a Friend
Intercept Pharma (NASDAQ: ICPT) traded sharply lower after the company said it will provide ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login